Market News AIOpen the app

Medicus Pharma got a warning from Nasdaq for not meeting market value rules but has now met a different requirement.

TroubleRead the original at SEC EDGAR
Neutral

Nasdaq lifted Medicus Pharma's market-value deficiency after it met an alternative equity test. It must show it still meets that test in its next report, so the notice does not settle whether it can stay listed.

MDCX · Medicus Pharma Ltd.

AI read · Neutral

The AI's read

That gives Medicus a route to keep its Nasdaq listing without meeting the market-value test. But it must show continued compliance with the equity test in its next report. If it does not, Nasdaq may delist the company, so the notice does not settle the listing question.

Get alerts for MDCX

Follow Medicus Pharma Ltd. (MDCX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MDCX
Free on the App Store and Google Play, or on the web.